13D Filing: OrbiMed Advisors and Adaptimmune Therapeutics PLC – ADR (ADAP)

Page 10 of 11

Page 10 of 11 – SEC Filing

Schedule II
The business and operations of OrbiMed Capital GP V LLC are managed by the executive officers and directors of its managing member, OrbiMed Advisors LLC, set forth on Schedule I attached hereto.

Follow Adaptimmune Therapeutics Plc (NASDAQ:ADAP)

Page 10 of 11